The polymerase chain reaction (PCR) was used to identify mycobacterial DNA sequences in uncultured clinical specimens. Two oligonucleotide primers derived from the sequence of a gene that codes for the 65-kilodalton antigen of Mycobacterium tuberculosis amplified DNA from all 11 species of mycobacteria tested. Diagnosis of mycobacterial infections is still a long process that traditionally depends on the isolation of the pathogen Mycobacterium tuberculosis, which can take up to 8 weeks because of the slow-growing nature of mycobacteria. Direct microscopy and Ziehl-Neelsen staining of clinical specimens lack sufficient sensitivities and specificities (1). The radiometric BACTEC system (Johnston Laboratories, Inc., Towson, Md.) has greatly reduced the time needed for detection, but it is still growth dependent. A major limitation of noncultural methods, such as the immunodiagnostic approach, is the lack of sensitivity. We and others have recently reported the direct identification of the presence of mycobacterial DNA with DNA probes (3, 6, 7, 10 
Diagnosis of mycobacterial infections is still a long process that traditionally depends on the isolation of the pathogen Mycobacterium tuberculosis, which can take up to 8 weeks because of the slow-growing nature of mycobacteria. Direct microscopy and Ziehl-Neelsen staining of clinical specimens lack sufficient sensitivities and specificities (1) . The radiometric BACTEC system (Johnston Laboratories, Inc., Towson, Md.) has greatly reduced the time needed for detection, but it is still growth dependent. A major limitation of noncultural methods, such as the immunodiagnostic approach, is the lack of sensitivity. We and others have recently reported the direct identification of the presence of mycobacterial DNA with DNA probes (3, 6, 7, 10) . However, the radioisotopes used in the labeling of DNA probes and the considerable time and expertise needed by DNA hybridization procedures are some of the obstacles of DNA probe technology to be accepted by clinical laboratories. More recently, a technique known as the polymerase chain reaction (PCR) (8) , which can amplify specific target DNA sequences many thousands of times in a matter of hours, has been applied in the rapid amplification and identification of many microorganisms, including mycobacteria (2, 4 (6) . The procedures for PCR have also been described earlier (5 (9) . The sequences of the oligonucleotide primers were (from the 5' to the 3' ends) CTAG GTCGGGACGGTGAGGCCAGG and CATTGCGAAGT GATTCCTCCGGAT. Another oligonucleotide of 40 bases in length located between the two primers was synthesized to be used as an internal probe, and its sequence was (from the 5' to the 3' ends) AGCGTAAGTAGCGGGGTTGCCGT CACCCGGTGACCCCCGT.
Southern blot hybridization. A 32P-labeled oligonucleotide probe was used for Southern blot hybridization analysis of PCR products (11) .
RESULTS
DNA prepared from M. tuberculosis and 10 other nontuberculosis mycobacteria, including M. avium, M. bovis BCG, M. chelonae, M. fortuitum, M. gordonae, M. kansasii, M. paratuberculosis, M. phlei, M. smegmatis, and M. xenopi, were used for PCR amplification. DNAs from all mycobacteria tested were amplified with the two primers used in this study. The size of DNA produced was 165 base pairs when M. tuberculosis and BCG DNAs were amplified.
DNAs from the other nine species of mycobacteria tested produced amplified DNA that were approximately 20 to 40 base pairs shorter than that from M. tuberculosis (Fig. 1) . DNAs prepared from 10 independent M. tuberculosis isolates cultured from clinical specimens gave DNAs of 165 base pairs after amplification, and another 10 similarly cultured isolates of nontuberculosis mycobacteria gave DNAs that were shorter in length (Fig. 2) . DNA from a total The authenticities of the amplified DNAs were established by two independent methods. Southern blot hybridization with an internal oligonucleotide DNA probe showed that the 165-base-pair DNAs from both M. tuberculosis and BCG can hybridize with the probe that was derived from the sequence that was located between the two primers (Fig. 3) . Comparison of the actual restriction endonuclease pattern of the amplified DNA products with that predicted from the known amplified DNA sequences and the locations of the restriction sites was illustrated by the disappearance of the original band of 165 base pairs after restriction endonuclease HpaII digestion and the appearance of two new bands of 85 and 79 base pairs. These results strongly suggest that the amplified DNA contains DNA sequences of M. tuberculosis (Fig. 4) .
The level of detection of mycobacterial DNA by PCR with the primers used in this study was determined by amplification serial dilutions of a purified M. tuberculosis DNA stock solution with a known concentration of about 0.1 pg of M. tuberculosis DNA, or approximately 40 cells, even in the presence of DNA equivalent to that in as many as 106 human cells (data not shown).
The sensitivity of detection of M. tuberculosis by PCR was determined by comparing the culture and DNA PCRs on a total of 284 clinical specimens (236 sputum and 48 pleural effusion specimens), and the results are given in Table 1 . M. tuberculosis DNA sequences could be found in 118 of 284 (41.5%) uncultured sputum or pleural effusion specimens by PCR, whereas the traditional growth-dependent culture method showed only a 17.3% positive rate for the same specimens (x2 = 40.28; P < 0.001). Nontuberculosis mycobacterial DNA sequences were detected in another five sputum and one pleural effusion specimen. All culturenegative but PCR DNA-positive specimens were collected from patients who had clinical signs indicative of tuberculosis, including characteristic radiographs, typical clinical manifestations of the disease, positive exposure history or overall sensitivity of 100% and a specificity of 62.6% when compared with culture results. Some of the clinical specimens that were positive by PCR but that were negative in culture were obtained from patients who were being treated for suspected tuberculosis. This is consistent with the fact that treated patients can still harbor mycobacteria long after culture for mycobacteria has become negative (2) . This may suggest that the DNA amplification method could detect mycobacteria that are unable to grow in vitro. The perfect sensitivity and seemingly low specificity of clinical specimen assays further illustrated the low efficiency of the growth-dependent culture method and the unique amplification nature of PCR. The detection limit of PCR was much better than that of any other technique available in detecting mycobacteria, including the DNA probe method (6, 10) . The high degree of sensitivity of PCR when combined with a low detection limit should be very useful in the early detection of mycobacterial infections, when bacterial cells may not be abundant enough for efficient or dependable direct staining and culture screening.
We found that the primers used in this study did not amplify DNA from the nonmycobacterial cells that we tested, including those commonly found in the respiratory tract. The fact that M. tuberculosis and BCG produced amplified DNAs with the same sizes was expected since the 65-kilodalton antigens of these two bacteria are identical, despite some reported differences in the DNA sequences in the region 3' to the open reading frame (9, 12, 13) . The ability of the primers evaluated in this study to differentiate M. tuberculosis and BCG from many other common nontuberculosis species of mycobacteria by a simple PCR is an added advantage of using PCR in terms of treating mycobacterial infections. The results here also suggest that it may be possible to design specific primers when more DNA sequence data become available that will allow the amplification and identification of specific species of nontuberculosis mycobacteria, either alone or in the presence of other microorganisms. The fact that DNA amplification can detect mycobacterial DNA sequences in the presence of vast excess amounts of human DNA makes it especially useful when quick results are required in certain clinical circumstances. Amplification may also be useful when large-scale screening of mycobacteria is indicated, such as in areas where tuberculosis is still a public health problem.
In summary, the results reported here suggest that with properly designed primers, DNA 
